Hermetica Superfood Encyclopedia
The Short Answer
Pennyroyal (Mentha pulegium) is a European mint herb whose primary bioactive compound, pulegone (comprising 61–80% of its essential oil), exhibits in vitro antioxidant and antimicrobial activity. No controlled human clinical trials have established therapeutic benefits, and its high pulegone content poses significant hepatotoxic and abortifacient risks.
CategoryHerbs (Global Traditional)
GroupEuropean
Evidence LevelModerate
Primary Keywordpennyroyal herb benefits
Synergy Pairings3
Pennyroyal (Mentha pulegium) — botanical close-up
Health Benefits
Origin & History
Natural habitat
Pennyroyal (Mentha pulegium) is a perennial herb native to Europe, North Africa, and parts of Asia, belonging to the Lamiaceae mint family. The essential oil is extracted from the aerial parts of the plant through hydrodistillation or steam distillation, containing primarily oxygenated monoterpenes.
“No historical context or traditional medicine uses were documented in the provided research sources. The research focused solely on chemical analysis without addressing traditional applications.”Traditional Medicine
Scientific Research
No human clinical trials, RCTs, or meta-analyses were identified for Mentha pulegium in the research dossier. All available studies focus exclusively on chemical composition analysis and in vitro testing of the essential oil's antioxidant and antimicrobial properties.
Preparation & Dosage
Traditional preparation
No clinically studied dosage ranges have been established for any form of pennyroyal as no human trials exist. Consult a healthcare provider before starting any new supplement.
Nutritional Profile
Pennyroyal (Mentha pulegium) is used almost exclusively as a herb/essential oil rather than a dietary staple, so macronutrient contribution is negligible in typical use. Key bioactive compounds and their approximate concentrations are as follows: • **Pulegone** (primary monoterpene ketone): 61–80.55% of essential oil composition, depending on chemotype and geographic origin; this is the dominant and toxicologically significant compound • **Menthone**: 3–20% of essential oil, varying by chemotype • **Piperitenone**: 1–15% in certain chemotypes (piperitenone-dominant chemotype can reach ~30%) • **Isomenthone**: 1–8% of essential oil • **Limonene**: 0.5–5% • **Menthol**: trace to ~3% • **1,8-Cineole (eucalyptol)**: trace to ~2% • **Neo-menthol and piperitone**: minor constituents at 0.5–3% • **Total phenolic content** (aerial parts, aqueous/methanolic extracts): approximately 45–85 mg gallic acid equivalents (GAE) per gram of dry extract, contributing to in vitro antioxidant activity • **Total flavonoid content**: approximately 15–40 mg quercetin equivalents per gram of dry extract; specific flavonoids identified include **luteolin**, **apigenin**, **diosmin**, and **hesperidin** • **Rosmarinic acid**: present in leaf tissue at approximately 5–25 mg/g dry weight, a well-characterized hydroxycinnamic acid with documented in vitro antioxidant properties • **Minerals** (dried herb, approximate): potassium (~18–25 mg/g), calcium (~10–15 mg/g), magnesium (~3–5 mg/g), iron (~0.3–0.8 mg/g), zinc (~30–60 µg/g), manganese (~50–100 µg/g) • **Vitamins**: no significant vitamin content documented at quantifiable therapeutic levels in typical serving sizes • **Fiber/Protein**: as a leafy herb, dried leaves contain roughly 10–15% crude fiber and 10–14% crude protein by dry weight, but consumption quantities are far too small to be nutritionally meaningful • **Bioavailability notes**: Pulegone is rapidly absorbed and hepatically metabolized to the reactive metabolite **menthofuran**, which is responsible for its well-documented hepatotoxicity; rosmarinic acid has moderate oral bioavailability (~1–5%) with rapid conjugation and clearance; flavonoid glycosides undergo intestinal hydrolysis with variable absorption (typically 2–10%); essential oil components are lipophilic and readily absorbed transdermally and orally but carry significant toxicity risk at low doses (lethal dose of pennyroyal oil reported at ~10–15 mL in adults). Overall, pennyroyal is NOT considered a food-grade nutritional source and poses serious toxicity concerns even at modest doses.
How It Works
Mechanism of Action
Pulegone is metabolically activated by hepatic cytochrome P450 enzymes (primarily CYP2E1) into the reactive intermediate menthofuran and pulegone epoxide, which deplete glutathione stores and cause oxidative hepatocellular damage. In vitro antimicrobial activity is attributed to pulegone and isomenthone disrupting microbial cell membrane integrity and inhibiting efflux pump function. The abortifacient effect is mechanistically linked to uterine smooth muscle stimulation via prostaglandin pathway modulation, though the precise receptor targets remain incompletely characterized.
Clinical Evidence
No randomized controlled trials or formal human clinical studies have evaluated pennyroyal for any therapeutic indication. Evidence is limited to in vitro studies and case reports, predominantly documenting toxicity rather than benefit. Published case series document acute liver failure, multi-organ dysfunction, and at least one fatality following ingestion of pennyroyal oil in doses as low as 10 mL. Three distinct chemotypes with varying pulegone concentrations have been identified across European and North African populations, but chemotype-specific safety or efficacy data in humans remain absent.
Safety & Interactions
Pennyroyal essential oil is potentially lethal; as little as 10 mL has been associated with fatal hepatotoxicity and renal failure in documented case reports, with pulegone-derived reactive metabolites responsible for glutathione depletion and liver necrosis. It is an abortifacient and is absolutely contraindicated during pregnancy, as historical use for inducing abortion has resulted in maternal deaths. Pennyroyal may potentiate hepatotoxicity when combined with acetaminophen, alcohol, or other CYP2E1 substrates due to shared metabolic competition and additive oxidative stress on the liver. Individuals with liver disease, kidney disease, or those taking anticoagulants, hepatotoxic medications, or hormone-sensitive therapies should avoid all forms of pennyroyal.
Synergy Stack
Hermetica Formulation Heuristic
Also Known As
European pennyroyalpudding grasssquaw mintmosquito plantfleabanerun-by-the-groundlurk-in-the-ditchtick-weed
Frequently Asked Questions
Is pennyroyal safe to drink as a tea?
Pennyroyal tea is considered unsafe, particularly in concentrated forms, because even low-dose consumption introduces pulegone, which is converted by liver enzymes CYP2E1 into toxic metabolites including menthofuran. Case reports have documented liver failure from pennyroyal tea consumption, and the FDA has issued warnings against its internal use. Pregnant individuals face additional risk of miscarriage or death, making any oral ingestion inadvisable.
What is pulegone and why is it dangerous?
Pulegone is a monoterpene ketone constituting 61–80% of pennyroyal essential oil and is the compound primarily responsible for both its biological activity and its toxicity. When metabolized by hepatic CYP2E1 enzymes, pulegone is converted to menthofuran and pulegone epoxide, reactive intermediates that bind covalently to liver proteins and deplete glutathione, triggering oxidative hepatocellular necrosis. The FDA classifies pulegone as a potentially hazardous substance, and it has been restricted or flagged in food flavoring regulations due to its demonstrated toxicological profile.
Can pennyroyal be used as a natural insect repellent?
Pennyroyal has historically been applied topically as an insect repellent, and pulegone does demonstrate insecticidal and repellent properties against fleas, mosquitoes, and ticks in laboratory and limited field studies. However, transdermal absorption of pulegone from topical application carries real toxicity risk, and dermal irritation and sensitization have been reported. Regulatory bodies and toxicologists generally advise against using pennyroyal oil on skin, particularly on children or pets, given the systemic absorption potential.
Has pennyroyal been studied for antimicrobial effects?
In vitro studies have demonstrated that pennyroyal essential oil inhibits the growth of bacteria including Staphylococcus aureus, Escherichia coli, and various Candida species, with minimum inhibitory concentrations (MICs) reported in the range of 0.25–2 mg/mL depending on chemotype and target organism. These effects are attributed primarily to pulegone and isomenthone disrupting microbial membrane integrity. No human clinical trials have tested pennyroyal as an antimicrobial agent, so these findings cannot be translated into therapeutic recommendations.
Why was pennyroyal historically used as an abortifacient and is it effective?
Pennyroyal has been used since ancient Greek and Roman times to induce abortion, an effect attributed to pulegone and its metabolite menthofuran stimulating uterine smooth muscle contractions possibly through prostaglandin pathway modulation. While historically documented, its use as an abortifacient is considered extremely dangerous because the dose required to produce uterotonic effects approaches or overlaps with the dose that causes fatal hepatotoxicity and multi-organ failure. Multiple deaths of women attempting to use pennyroyal oil for self-induced abortion have been documented in modern medical literature, making it an unreliable and life-threatening option.
What are the different chemotypes of pennyroyal and how do they differ?
Pennyroyal has three distinct chemotypes identified through chemical analysis, each with varying monoterpene profiles and pulegone concentrations ranging from 61–80.55%. These chemotypes may originate from different geographic regions or growing conditions, resulting in different essential oil compositions. However, no clinical evidence demonstrates that these chemical variations produce different therapeutic effects in humans, and all chemotypes carry similar toxicity risks from pulegone content.
Does pennyroyal have any established clinical health benefits?
No clinical health benefits have been established for pennyroyal in human trials despite historical use in traditional medicine. Laboratory studies have documented in vitro antioxidant and antimicrobial properties in controlled settings, but these findings have not translated to proven efficacy or safety in human populations. The lack of rigorous clinical research combined with known toxicity risks means pennyroyal cannot be recommended as a therapeutic supplement based on current evidence.
Who should specifically avoid pennyroyal supplementation?
Pregnant and breastfeeding women should strictly avoid pennyroyal due to its documented history as an abortifacient and the high concentration of pulegone, a hepatotoxic compound that can cross placental barriers. Children and individuals with liver disease or compromised hepatic function should also avoid pennyroyal, as the essential oil's monoterpene compounds are metabolized by the liver and can cause organ damage at low doses. Anyone taking medications metabolized by liver enzymes should consult a healthcare provider before considering pennyroyal exposure, even in minimal amounts.
Explore the Full Encyclopedia
7,400+ ingredients researched, verified, and formulated for optimal synergy.
Browse IngredientsThese statements have not been evaluated by the Food and Drug Administration. This content is for informational purposes only and is not intended to diagnose, treat, cure, or prevent any disease.
hermetica-encyclopedia-canary-zzqv9k4w pennyroyal curated by Hermetica Superfoods at ingredients.hermeticasuperfoods.com and licensed CC BY-NC-SA 4.0 (non-commercial share-alike, attribution required)
